Study of Atorvastatin Dose Dependent Reduction of Proteinuria
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
Randomized controlled double blind study of parallel groups to evaluate the comparative
effects of low-dose of atorvastatin on proteinuria in patients with stage 3 or 4 chronic
kidney disease.